Search

Your search keyword '"Novak, Richard"' showing total 940 results

Search Constraints

Start Over You searched for: Author "Novak, Richard" Remove constraint Author: "Novak, Richard"
940 results on '"Novak, Richard"'

Search Results

1. Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial

2. Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.

3. Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

4. Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.

6. Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.

7. Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients

9. Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum

10. Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data.

11. CD4/CD8 Ratio and Cancer Risk Among Adults With HIV

12. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

14. Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial

15. Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

16. Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

17. Risk of COVID-19 after natural infection or vaccination

19. The relationship between the epigenetic aging biomarker “grimage” and lung function in both the airway and blood of people living with HIV: An observational cohort study

20. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

21. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

23. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada

24. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets

26. HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers

27. Microbiome Composition and Function Drives Wound-Healing Impairment in the Female Genital Tract.

29. Service delivery challenges in HIV care during the first year of the COVID?19 pandemic: results from a site assessment survey across the global IeDEA consortium

31. Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips

32. On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology

33. Robotic fluidic coupling and interrogation of multiple vascularized organ chips

35. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.

36. Single cell measurement of telomerase expression and splicing using microfluidic emulsion cultures

37. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

39. Microfluidic Technologies for Quantitative Single Cell Analysis

40. Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

42. Donepezil Nanoemulsion Induces a Torpor-like State with Reduced Toxicity in Nonhibernating Xenopus laevisTadpoles

43. Identification of pharmacological inducers of a reversible hypometabolic state for whole organ preservation

44. Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial

45. Brief Report: Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors and the Risk of Cancer Among People With HIV.

46. Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions : Results of a Randomized Placebo-Controlled Trial

48. Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial

Catalog

Books, media, physical & digital resources